Murine cytomegalovirus immediate-early promoter directs astrocyte- specific expression in transgenic mice

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 735-743

  Aiba Masago, Sonomi ^a   Baba, Satoshi ^a   Li, Ren Yong ^a   Shinmura, Yuichiro ^a   Kosugi, Isao ^a   Arai, Yoshifumi ^a   Nishimura, Masahiko ^a   Tsutsui, Yoshihiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CALCIUM IONOPHORE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; CELL SPECIFICITY; CELL TYPE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GENE EXPRESSION; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SKELETAL MUSCLE; STOMACH; TRANSGENIC MOUSE;

EID: 0032996754     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65320-5     Document Type: Article

References (50)

1. Weller TH: The cytomegalovirus: ubiquitous agents with protean clinical manifestation. N Engl J Med 1971, 285:203-214
2. Becroft DMO: Prenatal cytomegalovirus infection: epidemiology, pathology, pathogenesis. Perspectives in Pediatric Pathology, Vol. 6: Infectious Diseases. Edited by HS Rosenberg and J Bernstein. New York, Masson Publishing USA, 1981, pp 203-241
3. Bale JF: Human cytomegalovirus infection and disorders of the nervous system. Arch Neurol 1984, 41:310-320
4. Ho M: Congenital and perinatal human cytomegalovirus infections. Cytomegalovirus: Biology and Infection, ed 2. New York, Plenum Press, 1991, pp 205-227
5. Britt WJ, Alford CA: Cytomegalovirus Virology, ed 3. Edited by Fiels BN, Knipe DM, Howley PM. Philadelphia, Lippincott-Raven, 1996 pp 2493-2523
6. Griffith PD, Grundy JE: Molecular biology and immunology of cytomegalovirus. Biochem J 1987, 241:313-324
7. Mocarski ES Jr: Cytomegalovirus and their replication. Virology, ed 3. Edited by Fiels BN, Knipe DM, Howley PM. Philadelphia, Lippincott-Raven, 1996, pp 2447-2492
8. Mocarski ES Jr, Kemble GW: Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology 1996, 39:320-330
9. Staczek J: Animal cytomegaloviruses. Microbiol Rev 1990, 54:247-265
10. Tsutsui Y, Kashiwai A, Kawamura N, Kadota C: Microphthalmia and cerebral atrophy induced in mouse embryos by infection with murine cytomegalovirus in midgestation. Am J Pathol 1993, 143:804-812
11. Tsutsui Y: Developmental disorders of the mouse brain induced by murine cytomegalovirus: animal models for congenital cytomegalovirus infection. Pathol Int 1995, 45:91-102
12. Nelson JA, Gnann JW, Wahren B: Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol 1990, 154:75-100
13. Ghazal P, Nelson JA: Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis. Molecular Aspects of Human Cytomegalovirus Diseases. Edited by Becker Y, Darai G, Huang E-S. Berlin, Springer-Verlag, 1993, pp 360-383
14. Koedood M, Fichtel A, Meier P, Mitchell PJ: Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol 1995, 69:2194-2207
15. Fritschy J-M, Brandner S, Aguzzi A, Koedood M, Lüscher B, Mitchell PJ: Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice. J Neurosci 1996, 16:2275-2282
16. Baskar JF, Smith PP, Nilaver G, Jupp RA, Hoffmann S, Peffer NJ, Tenney DJ, Colberg-Poley AM, Ghazal P, Nelson JA: The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol 1996, 70:3207-3214
17. Baskar JF, Smith PP, Ciment GS, Hoffmann S, Tucker C, Tenney DJ, Colberg-Poley AM, Nelson JA, Ghazal P: Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J Virol 1996, 70:3215-3226
18. Schmid EV, Christoph G, Zeller R, Leder P: The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol Cell Biol 1990, 10:4406-4411
19. Marks JR, Mercer JA, Spector DH: Transcription of mouse embryo cells permissively infected by murine cytomegalovirus. Virology 1983, 131:247-254
20. Keil GM, Ebeling-Keil A, Koszinowski UH: Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection. J Virol 1984, 50: 784-795
21. Ebihara K, Minamishima Y: Protective effects of biological response modifiers on murine cytomegalovirus infection. J Virol 1984, 51:117-122
22. Mercer EH, Hoyle GW, Kapur RJ, Brinster RL, Palmiter LD: The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron 1991, 7:703-716
23. Hogan B, Costantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1986, pp 153-186
24. Innis MA, Gelfand DH, Sninsky JJ, White TJ: PCR Protocols: A Guide to Methods and Applications. San Diego, Academic Press, 1990
25. Shinmura Y, Aiba-Masago S, Kosugi I, Li R-Y, Baba S, Tsutsui Y: Differential expression of the immediate-early and early antigens in neuronal and glial cells of developing mouse brains infected with a murine cytomegalovirus. Am J Pathol 1997, 151:1331-1340
26. Togashi H, Sasaki M, Frohman E, Taira E, Ratan RR, Dawson TM, Dawson VL: Neuronal (type I) nitric oxide synthase regulates nuclear factor κB activity and immunologic (type II) nitric oxide synthase expression. Proc Natl Acad Sci 1997, 94:2676-2680
27. Norris JG, Tang L, Sparacio SM, Benveniste EN: Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α. J Immunol 1994, 152:841-850
28. Jain VK, Magrath IT: A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range: application to quantitation of β-galactosidase in lacZ-transfected cells. Anal Biochem 1991, 199:119-124
29. Miller RH, Raff MC: Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurosci 1984, 4:585-592
30. Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk H-D, Krüger DH: Stimulation of the human cytomegalovirus IE enhancer/ promoter in HL-60 cells by TNF-α is mediated via induction of NF-κB. Virology 1995, 208:197-206
31. Furth PA, Henninghausen L, Baker C, Beatty B, Woychick R: The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res 1991, 19:6205-6208
32. Kothary R, Barton SC, Franz T, Norris ML, Hettle S, Surani MAH: Unusual cell specific expression of a major human cytomegalovirus immediate early gene promoter-lacZ hybrid gene in transgenic mouse embryos. Mech Dev 1991, 35:25-31
33. Palmiter SD, Brinster RL: Germ-line transformation of mice. Annu Rev Genet 1986, 20:465-499
34. Huang TH, Oka T, Asai T, Okada T, Merrills BW, Gertson PN, Whitson RH, Itakura K: Repression by a differentiation-specific factor of the human cytomegalovirus enhancer. Nucleic Acids Res 1996, 24: 1695-1701
35. Ferrer I, Blanco R, Rivera R, Carmona M, Ballabriga J, Olivé M, Planas AM: CREB-1 and CREB-2 immunoreactivity in the rat brain. Brain Res 1996, 712:159-164
36. Kara CJ, Liou H-C, Ivashkiv LB, Glimcher LH: A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. Mol Cell Biol 1990, 10:1347-1357
37. Stamminger T, Fickenscher H, Fleckenstein B: Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J Gen Virol 1990, 71:105-113
38. Lang D, Gebert S, Arlt H, Stamminger T: Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol 1995, 69:6030-6037
39. Rawlinson WD, Farrell HE, Barrell BG: Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 1996, 70:8833-8849
40. Perlman JM, Argyle C: Lethal cytomegalovirus infection in preterm infant: clinical, radiological, and neurological findings. Ann Neurol 1992, 31:64-68
41. Wiley CA, Nelson JA: Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol 1988, 133:73-81
42. Kashiwai A, Kawamura N, Kadota C, Tsutsui Y: Susceptibility of mouse embryo to murine cytomegalovirus infection in early and midgestation. Arch Virol 1992, 127:37-48
43. Tsutsui Y, Kashiwai A, Kawamura N, Aiba-Masago S, Kosugi I: Prolonged infection of mouse brain neurons with murine cytomegalovirus after pre- and perinatal infection. Arch Virol 1995, 140:1725-1736
44. Balthesen M, Messerle M, Reddehase MJ: Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993, 67: 5360-5366
45. Collins T, Pomeroy C, Jordan MC: Detection of latent cytomegalovirus DNA in diverse organs of mice. J Infect Dis 1993, 168:725-729
46. Manning WC, Stoddart CA, Lagenaur LA, Abenes GB, Mocarski ES Jr: Cytomegalovirus determination of replication in salivary glands. J Virol 1992, 66:3794-3802
47. Reddehase MJ, Balthesen M, Rapp M, Jonjic S, Pavic I, Koszinowski UH: The combination of primary infection define the load of recurrent cytomegalovirus disease. J Exp Med 1993, 179:185-193
48. Gribaudo G, Ravaglia S, Gaboli M, Gariglio M, Cavallo R, Landolfo S: Interferon-α inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-κB activity. Virology 1995, 211:251-260
49. Yurochko AD, Kowalik TF, Huong S-M, Huang E-S: Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J Virol 1995, 69:5391-5400
50. Hermiston TW, Malone CL, Stinski MF: human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter. J Virol 1990, 64:3532-3536